Us Physicalrapy Stock Operating Margin

USPH Stock

USD 105.40 1.32 1.24%

US Physicalrapy fundamentals help investors to digest information that contributes to US Physicalrapy's financial success or failures. It also enables traders to predict the movement of USPH Stock. The fundamental analysis module provides a way to measure US Physicalrapy's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to US Physicalrapy stock.

		Last Reported	Projected for Next Year
	Operating Profit Margin	0.12	0.07

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

US Physicalrapy Company Operating Margin Analysis

US Physicalrapy's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

Operating Income

Revenue

100

More About Operating Margin | All Equity Analysis

Current US Physicalrapy Operating Margin

0.09 %

Most of US Physicalrapy's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, US Physicalrapy is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

USPH Operating Margin Driver Correlations

Understanding the fundamental principles of building solid financial models for US Physicalrapy is extremely important. It helps to project a fair market value of USPH Stock properly, considering its historical fundamentals such as Operating Margin. Since US Physicalrapy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of US Physicalrapy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of US Physicalrapy's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Short Term Investments	Net Tangible Assets	Total Permanent Equity	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Accumulated Depreciation	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.76	0.9	0.77	0.95	0.98	0.92	0.93	0.99	-0.4	0.55	0.88	-0.33	0.91	0.05	0.07	-0.84	0.76	0.88	0.85	0.65	-0.89	0.82	0.84	0.53	0.78
Total Stockholder Equity	0.98		0.63	0.89	0.67	0.93	0.93	0.97	0.88	0.95	-0.46	0.61	0.82	-0.38	0.87	0.07	-0.02	-0.78	0.73	0.85	0.78	0.58	-0.82	0.82	0.8	0.63	0.85
Net Debt	0.76	0.63		0.74	0.92	0.73	0.84	0.48	0.82	0.81	-0.26	0.36	0.84	-0.24	0.77	0.11	0.15	-0.8	0.55	0.74	0.75	0.56	-0.81	0.57	0.72	0.02	0.32
Retained Earnings	0.9	0.89	0.74		0.75	0.97	0.86	0.75	0.8	0.89	-0.7	0.8	0.74	-0.66	0.72	0.32	-0.25	-0.67	0.75	0.71	0.83	0.66	-0.91	0.65	0.64	0.24	0.52
Accounts Payable	0.77	0.67	0.92	0.75		0.77	0.84	0.56	0.73	0.82	-0.38	0.46	0.9	-0.35	0.85	0.16	-0.01	-0.87	0.51	0.84	0.68	0.48	-0.76	0.52	0.75	0.18	0.39
Net Receivables	0.95	0.93	0.73	0.97	0.77		0.9	0.84	0.82	0.94	-0.64	0.75	0.82	-0.58	0.79	0.25	-0.18	-0.73	0.79	0.8	0.84	0.68	-0.9	0.71	0.7	0.4	0.62
Total Liab	0.98	0.93	0.84	0.86	0.84	0.9		0.87	0.96	0.98	-0.33	0.48	0.93	-0.26	0.95	0.02	0.13	-0.91	0.69	0.92	0.81	0.59	-0.86	0.82	0.88	0.5	0.76
Total Current Assets	0.92	0.97	0.48	0.75	0.56	0.84	0.87		0.81	0.88	-0.36	0.51	0.78	-0.27	0.86	-0.03	0.0	-0.75	0.63	0.84	0.65	0.45	-0.66	0.82	0.79	0.8	0.95
Short Term Debt	0.93	0.88	0.82	0.8	0.73	0.82	0.96	0.81		0.91	-0.23	0.38	0.8	-0.16	0.86	-0.03	0.26	-0.78	0.65	0.78	0.81	0.6	-0.83	0.8	0.83	0.39	0.71
Intangible Assets	0.99	0.95	0.81	0.89	0.82	0.94	0.98	0.88	0.91		-0.36	0.51	0.92	-0.3	0.92	0.05	0.1	-0.88	0.74	0.91	0.85	0.65	-0.9	0.83	0.85	0.49	0.73
Good Will	-0.4	-0.46	-0.26	-0.7	-0.38	-0.64	-0.33	-0.36	-0.23	-0.36		-0.97	-0.3	0.99	-0.21	-0.63	0.83	0.2	-0.37	-0.24	-0.33	-0.25	0.39	-0.19	-0.16	-0.05	-0.13
Common Stock	0.55	0.61	0.36	0.8	0.46	0.75	0.48	0.51	0.38	0.51	-0.97		0.42	-0.94	0.35	0.69	-0.73	-0.33	0.49	0.38	0.51	0.4	-0.52	0.33	0.35	0.16	0.29
Long Term Debt	0.88	0.82	0.84	0.74	0.9	0.82	0.93	0.78	0.8	0.92	-0.3	0.42		-0.24	0.95	0.02	0.05	-0.97	0.58	0.96	0.68	0.48	-0.74	0.76	0.87	0.51	0.67
Treasury Stock	-0.33	-0.38	-0.24	-0.66	-0.35	-0.58	-0.26	-0.27	-0.16	-0.3	0.99	-0.94	-0.24		-0.13	-0.63	0.85	0.13	-0.33	-0.17	-0.28	-0.21	0.36	-0.11	-0.07	0.05	-0.02
Property Plant Equipment	0.91	0.87	0.77	0.72	0.85	0.79	0.95	0.86	0.86	0.92	-0.21	0.35	0.95	-0.13		-0.08	0.17	-0.97	0.55	0.96	0.68	0.44	-0.71	0.77	0.91	0.61	0.8
Current Deferred Revenue	0.05	0.07	0.11	0.32	0.16	0.25	0.02	-0.03	-0.03	0.05	-0.63	0.69	0.02	-0.63	-0.08		-0.59	0.02	0.13	-0.05	0.34	0.32	-0.13	-0.08	0.17	-0.24	-0.14
Short Term Investments	0.07	-0.02	0.15	-0.25	-0.01	-0.18	0.13	0.0	0.26	0.1	0.83	-0.73	0.05	0.85	0.17	-0.59		-0.11	0.03	0.09	0.16	0.17	-0.11	0.13	0.19	0.05	0.15
Net Tangible Assets	-0.84	-0.78	-0.8	-0.67	-0.87	-0.73	-0.91	-0.75	-0.78	-0.88	0.2	-0.33	-0.97	0.13	-0.97	0.02	-0.11		-0.51	-0.95	-0.64	-0.39	0.67	-0.72	-0.9	-0.52	-0.7
Total Permanent Equity	0.76	0.73	0.55	0.75	0.51	0.79	0.69	0.63	0.65	0.74	-0.37	0.49	0.58	-0.33	0.55	0.13	0.03	-0.51		0.57	0.8	0.77	-0.78	0.57	0.49	0.24	0.45
Long Term Debt Total	0.88	0.85	0.74	0.71	0.84	0.8	0.92	0.84	0.78	0.91	-0.24	0.38	0.96	-0.17	0.96	-0.05	0.09	-0.95	0.57		0.65	0.42	-0.71	0.71	0.86	0.63	0.77
Capital Surpluse	0.85	0.78	0.75	0.83	0.68	0.84	0.81	0.65	0.81	0.85	-0.33	0.51	0.68	-0.28	0.68	0.34	0.16	-0.64	0.8	0.65		0.87	-0.92	0.63	0.74	0.15	0.49
Deferred Long Term Liab	0.65	0.58	0.56	0.66	0.48	0.68	0.59	0.45	0.6	0.65	-0.25	0.4	0.48	-0.21	0.44	0.32	0.17	-0.39	0.77	0.42	0.87		-0.75	0.47	0.51	0.03	0.3
Accumulated Depreciation	-0.89	-0.82	-0.81	-0.91	-0.76	-0.9	-0.86	-0.66	-0.83	-0.9	0.39	-0.52	-0.74	0.36	-0.71	-0.13	-0.11	0.67	-0.78	-0.71	-0.92	-0.75		-0.63	-0.63	-0.13	-0.44
Short Long Term Debt	0.82	0.82	0.57	0.65	0.52	0.71	0.82	0.82	0.8	0.83	-0.19	0.33	0.76	-0.11	0.77	-0.08	0.13	-0.72	0.57	0.71	0.63	0.47	-0.63		0.77	0.58	0.77
Net Invested Capital	0.84	0.8	0.72	0.64	0.75	0.7	0.88	0.79	0.83	0.85	-0.16	0.35	0.87	-0.07	0.91	0.17	0.19	-0.9	0.49	0.86	0.74	0.51	-0.63	0.77		0.57	0.79
Net Working Capital	0.53	0.63	0.02	0.24	0.18	0.4	0.5	0.8	0.39	0.49	-0.05	0.16	0.51	0.05	0.61	-0.24	0.05	-0.52	0.24	0.63	0.15	0.03	-0.13	0.58	0.57		0.9
Capital Stock	0.78	0.85	0.32	0.52	0.39	0.62	0.76	0.95	0.71	0.73	-0.13	0.29	0.67	-0.02	0.8	-0.14	0.15	-0.7	0.45	0.77	0.49	0.3	-0.44	0.77	0.79	0.9

Click cells to compare fundamentals

A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.

Competition

Predict US Physicalrapy

Operating Profit Margin Over Time

USPH Pretax Profit Margin

Pretax Profit Margin

0.088

As of now, US Physicalrapy's Pretax Profit Margin is decreasing as compared to previous years.

Based on the recorded statements, US Physicalrapy has an Operating Margin of 0.0929%. This is 100.26% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 101.69% lower than that of the firm.

USPH Operating Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses US Physicalrapy's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of US Physicalrapy could also be used in its relative valuation, which is a method of valuing US Physicalrapy by comparing valuation metrics of similar companies.

US Physicalrapy is currently under evaluation in operating margin category among related companies.

US Physicalrapy ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, US Physicalrapy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to US Physicalrapy's managers, analysts, and investors.

Environmental

Governance

Social

USPH Fundamentals

	Return On Equity	0.0647
	Return On Asset	0.0443
	Profit Margin	0.05 %
	Operating Margin	0.09 %
	Current Valuation	1.9 B
	Shares Outstanding	15.07 M
	Shares Owned By Insiders	1.62 %
	Shares Owned By Institutions	98.38 %
	Number Of Shares Shorted	706.97 K
	Price To Earning	34.35 X
	Price To Book	3.25 X
	Price To Sales	2.59 X
	Revenue	604.8 M
	Gross Profit	112.02 M
	EBITDA	85.25 M
	Net Income	18.14 M
	Cash And Equivalents	48.57 M
	Cash Per Share	3.73 X
	Total Debt	258.59 M
	Debt To Equity	0.57 %
	Current Ratio	1.43 X
	Book Value Per Share	31.84 X
	Cash Flow From Operations	82.81 M
	Short Ratio	9.58 X
	Earnings Per Share	1.16 X
	Price To Earnings To Growth	6.94 X
	Target Price	121.38
	Number Of Employees	3.9 K
	Beta	1.39
	Market Capitalization	1.59 B
	Total Asset	1.03 B
	Retained Earnings	223.77 M
	Working Capital	131.19 M
	Current Asset	60.18 M
	Current Liabilities	19.01 M
	Annual Yield	0.02 %
	Five Year Return	1.01 %
	Net Asset	1.03 B
	Last Dividend Paid	1.73

About US Physicalrapy Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze US Physicalrapy's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of US Physicalrapy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of US Physicalrapy based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

VWITX	Vanguard Intermediate Term Tax Exempt
VGSTX	Vanguard Star Fund
VFIAX	Vanguard 500 Index
VTCLX	Vanguard Tax Managed Capital
VTSAX	Vanguard Total Stock

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:

How To Invest In USPH

Details

Is USPH Stock a good investment?

Details

What is US Physicalrapy's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out US Physicalrapy Piotroski F Score and US Physicalrapy Altman Z Score analysis.

For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is US Physicalrapy's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.19)

Dividend Share

1.73

Earnings Share

1.16

Revenue Per Share

41.242

Quarterly Revenue Growth

0.048

The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Us Physicalrapy Stock Operating Margin

US Physicalrapy Company Operating Margin Analysis

Operating Margin

Operating Income

Revenue

100

Current US Physicalrapy Operating Margin

USPH Operating Margin Driver Correlations

USPH Pretax Profit Margin

Pretax Profit Margin

0.088

USPH Operating Margin Peer Comparison

US Physicalrapy ESG Sustainability

USPH Fundamentals

About US Physicalrapy Fundamental Analysis

Currently Active Assets on Macroaxis

Complementary Tools for USPH Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY